These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4201424)

  • 21. Turnover of dihydrofolate reductase in rapidly dividing cells.
    Jackson RC; Huennekens FM
    Arch Biochem Biophys; 1973 Jan; 154(1):192-8. PubMed ID: 4144053
    [No Abstract]   [Full Text] [Related]  

  • 22. Methotrexate analogues. 18. Enhancement of the antitumor effect of methotrexate and 3',5'-dichloromethotrexate by the use of lipid-soluble diesters.
    Rosowsky A; Yu CS
    J Med Chem; 1983 Oct; 26(10):1448-52. PubMed ID: 6620303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of the carboxamide of NADPH, with Lactobacillus casei dihydrofolate reductase.
    Dwivedi CM; Plante LT; Kisliuk RL; Pastore EJ; Verma SP; Wallach DF
    Arch Biochem Biophys; 1982 Jan; 213(1):338-40. PubMed ID: 6800305
    [No Abstract]   [Full Text] [Related]  

  • 24. The return of antimetabolite sensitivity in methotrexate- and 6-mercaptopurine-resistant L1210 murine leukemia by the process of adaptive selection.
    Wallerstein H; Slater LM; Eng B; Calman N
    Cancer Res; 1972 Oct; 32(10):2235-40. PubMed ID: 5080766
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells.
    Whitehead VM
    Cancer Res; 1977 Feb; 37(2):408-12. PubMed ID: 832265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The intracellular concentration dependence of antifolate inhibition of DNA synthesis in L1210 leukemia cells.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1974 Dec; 34(12):332-40. PubMed ID: 4429954
    [No Abstract]   [Full Text] [Related]  

  • 27. Reduction of oxidised folates by dihydrofolate reductase from methotrexate-resistant Lactobacillus casei.
    McIntyre LJ; Harding NG
    Biochim Biophys Acta; 1977 Jun; 482(2):261-71. PubMed ID: 18181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The isolation of dihydrofolate reductases by affinity chromatography on folate-sepharose.
    Whiteley JM; Henderson GB; Russell A; Singh P; Zevely EM
    Anal Biochem; 1977 May; 79(1-2):42-51. PubMed ID: 405885
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of allopurinol on the therapeutic efficacy of methotrexate.
    Grindey GB; Moran RG
    Cancer Res; 1975 Jul; 35(7):1702-5. PubMed ID: 1131828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural comparisons of complexes of methotrexate analogues with Lactobacillus casei dihydrofolate reductase by two-dimensional 1H NMR at 500 MHz.
    Hammond SJ; Birdsall B; Feeney J; Searle MS; Roberts GC; Cheung HT
    Biochemistry; 1987 Dec; 26(26):8585-90. PubMed ID: 3126805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydrofolate reductase from Lactobacillus casei: N-terminal sequence and comparison with the substrate binding region of other reductases.
    Batley KE; Morris HR
    Biochem Biophys Res Commun; 1977 Apr; 75(4):1010-4. PubMed ID: 405008
    [No Abstract]   [Full Text] [Related]  

  • 32. The metabolic fate of tritiated methotrexate. I. Absorption, excretion, and distribution in mice, rats, dogs and monkeys.
    Henderson ES; Adamson RH; Denham C; Oliverio VT
    Cancer Res; 1965 Aug; 25(7):1008-17. PubMed ID: 4954195
    [No Abstract]   [Full Text] [Related]  

  • 33. Reappearance of dihydrofolate reductase in rodent tissues following methotrexate administration.
    Ho DH; Werkheiser WC
    J Pharmacokinet Biopharm; 1975 Aug; 3(4):265-76. PubMed ID: 1185524
    [No Abstract]   [Full Text] [Related]  

  • 34. Thermodynamic characterization of the interactions of methotrexate with dihydrofolate reductase by quantitative affinity chromatography.
    Waltham MC; Holland JW; Nixon PF; Winzor DJ
    Biochem Pharmacol; 1988 Feb; 37(3):541-5. PubMed ID: 3122765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue pharmacokinetics, inhibition of DNA synthesis and tumor cell kill after high-dose methotrexate in murine tumor models.
    Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
    Cancer Res; 1976 Dec; 36(12):4672-8. PubMed ID: 1000510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further evaluation of the antitumor activity of homofolate and its reduced derivatives against methotrexate-insensitive tumors.
    Mishra LC; Mead JA
    Chemotherapy; 1972; 17(4):283-92. PubMed ID: 4504773
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunologic heterogeneity of dihydrofolate reductase from methotrexate sensitive and resistant L1210 leukemia cells.
    Iqbal MP; Rothenberg SP; Larosa C
    Proc Soc Exp Biol Med; 1985 Oct; 180(1):98-102. PubMed ID: 2412235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dihydrofolate reductase: specificity and conformational change.
    Roberts GC
    Biochem Soc Trans; 1987 Aug; 15(4):762-6. PubMed ID: 3119395
    [No Abstract]   [Full Text] [Related]  

  • 39. Discussion paper: amethopterin linked covalently to water-soluble macromolecules.
    Harding NG
    Ann N Y Acad Sci; 1971 Nov; 186():270-83. PubMed ID: 5002437
    [No Abstract]   [Full Text] [Related]  

  • 40. Reduced forms of aminopterin and methotrexate in L1210 lymphoma.
    Makulu DR; Fölsch E
    J Natl Cancer Inst; 1977 Jul; 59(1):245-9. PubMed ID: 875056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.